In this cohort study of critically ill patients with septic shock from the Protocolized Care for Early Septic Shock (ProCESS) trial,19 we explored whether higher levels of [TIMP-2] × [IGFBP7], measured nearly simultaneously with assessment of AKI, could identify patients with reduced survival among those at the same functional AKI stage. Here, TIMP2 is linked to acute kidney injury.